Tag

Direct To Consumer

All articles tagged with #direct to consumer

A 28-Year-Old CEO Turns Nostalgia Into a Refurbished-Gadget Business
business1 day ago

A 28-Year-Old CEO Turns Nostalgia Into a Refurbished-Gadget Business

London Jackson (Kickback) builds a direct-to-consumer line of reimagined retro tech and refurbished gadgets (e.g., Motorola Razr phones, portable CD players, 2000s-style cameras) targeting Gen Z, using social media to market an offline, nostalgia-driven lifestyle. In 2025 Kickback surpassed $750,000 in revenue with over 7,000 products sold and about $460,000 in gross profit, backed by roughly $300,000 in VC funding. The company relies on a network of refurbishers, recently hired a COO to scale, and is expanding with new product lines and collaborations like a Brent Faiyaz-inspired camera line.

D’Amaro Unveils Disney’s Growth Playbook: Creative Excellence, Disney+ at the Core, and Global Expansion
business21 days ago

D’Amaro Unveils Disney’s Growth Playbook: Creative Excellence, Disney+ at the Core, and Global Expansion

On Disney’s Q2 FY26 earnings call, new CEO Josh D’Amaro outlined a disciplined growth plan with Disney+ at the center, three priorities (creative excellence, a more connected direct-to-consumer experience, and technology), and a push for international streaming growth. He highlighted IP momentum (Zootopia 2 with $1.9B global box office and 1B hours streamed on Disney+) and ongoing investments across films, experiences (Disney Adventures World, World of Frozen) and ESPN’s direct-to-consumer evolution, while acknowledging near-term variability but long-term value from Disney’s brands and platforms.

Nike's Slow-Burn Comeback: Back to Sports, Partners, and Product
business1 month ago

Nike's Slow-Burn Comeback: Back to Sports, Partners, and Product

Nike is pursuing a slow-moving turnaround under CEO Elliott Hill, refocusing on sports, rebuilding wholesale partnerships, and returning to product innovation after a period of aggressive Direct-to-Consumer emphasis that hurt shelves and margins. The strategy—centered on Hill’s Win Now plan, reorganization by sport, and reducing flooded inventory—faces headwinds from tariff pressure and a weak China market where local brands are gaining ground, while North America shows some growth and new product initiatives (Mind sneakers, SKIMS collab). Progress is evident but progress is gradual, with 12–18 month timelines for new product cycles and sustained wholesale restoration needed for a true recovery.

DTC Drivers Step Up in 2026 Golf Market
sports1 month ago

DTC Drivers Step Up in 2026 Golf Market

In 2026, direct-to-consumer brands Takomo, Vice Golf, Ben Hogan, MacGregor, and LA Golf are proving you can get genuinely competitive drivers without the big-brand premium. MyGolfSpy’s testing shows DTC models delivering strong forgiveness (MacGregor Tourney Max 8.7; LA Golf 8.9) and solid distance, with LA Golf posting the best accuracy among DTC and top results for slower swing speeds, while prices range from about $249 to $649. The overall field’s top distance still belonged to Callaway’s Quantum Max (9.5 distance score), but the gap between DTC and mainstream drivers is shrinking. If you’re a casual to mid-handicap player who values forgiveness and value, a DTC driver can be a smart fit; however, those needing every yard or who must demo clubs beforehand should approach with fitting in mind.

Big Arch, Bigger PR: What McDonald's CEO's Instagram Says About Direct-to-Consumer Marketing
business2 months ago

Big Arch, Bigger PR: What McDonald's CEO's Instagram Says About Direct-to-Consumer Marketing

An BI writer frames Kempczinski’s Instagram posts about the Big Arch as part of a broader ‘going direct’ PR trend, notes the viral backlash over his tiny bite, and shares trying the burger herself (it's tasty); the piece argues the posts may be aimed more at McDonald's employees and franchisees than the general public, illustrating a shifting corporate communications strategy.

politics3 months ago

TrumpRx launches discount drug portal, aims to cut costs but skeptics doubt sweeping savings

President Trump unveiled TrumpRx, a direct-to-consumer site offering discounts on about 40 branded medicines from five major drugmakers with GoodRx backing; experts say savings may be muted for many since insurance plans and deductibles often yield lower costs, and pricing details remain unclear. The administration touts it as transformative, but critics warn it could curb competition and that broader Medicare drug-price negotiations would be more effective. A potential Express Scripts agreement could expand coverage if the regulatory environment allows, signaling that Congress may need to act to count purchases toward deductibles.

TrumpRx: White House rolls out cash-pay drug hub to lower costs
politics3 months ago

TrumpRx: White House rolls out cash-pay drug hub to lower costs

The White House announced TrumpRx, a direct-to-consumer hub that directs cash-paying patients to discounts offered by drugmakers on their own sites, as part of efforts to lower U.S. prescription costs. The site does not sell drugs itself and may not benefit insured patients who rely on coverage, but could help uninsured or underinsured access drugs not widely covered, such as obesity medications; participating makers include Lilly and Novo Nordisk, with prices advertised (e.g., Ozempic and Wegovy at about $350/month) amid broader debated savings, since actual prices often depend on rebates and payer contracts. The overall impact on out-of-pocket costs remains uncertain.

President Launches TrumpRx Website and Pfizer Deal to Lower Drug Prices
healthcare7 months ago

President Launches TrumpRx Website and Pfizer Deal to Lower Drug Prices

President Trump announced a deal with Pfizer to sell drugs directly to consumers at discounted prices through a new website, TrumpRx.gov, aiming to align U.S. drug prices with those in other developed countries. The initiative includes Pfizer's commitment to offer new drugs at the same price globally and to provide drugs to Medicaid at most-favored-nation prices, though the impact on average consumers and Medicaid beneficiaries remains uncertain. The website is expected to launch in 2026, but critics suggest the measure may be more symbolic than transformative.

Trump Announces 'TrumpRx' Website to Lower US Drug Prices
healthcare7 months ago

Trump Announces 'TrumpRx' Website to Lower US Drug Prices

President Trump announced the upcoming launch of 'TrumpRx,' a website aimed at allowing Americans to buy prescription drugs directly at discounted prices, with the site expected to be available in early 2026. This initiative follows Pfizer's agreement to lower drug prices for U.S. consumers and aligns with broader efforts to reduce pharmaceutical costs through new pricing strategies and manufacturing investments.

health-policy8 months ago

Trump Signs Executive Order to Regulate Pharmaceutical Advertising

President Trump announced plans to crack down on pharmaceutical advertising, aiming to address concerns over overmedicalization of children and the influence of direct-to-consumer drug ads, which have increased prescriptions and raised health risks. The move seeks to strengthen FDA oversight, especially on social media, to ensure more balanced and responsible drug marketing.